EA
VCYT icon

Ellsworth Advisors’s Veracyte VCYT Stock Holding History

Ellsworth Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,357
Closed -$360K – 154
2020
Q4 		$360K Buy
7,357
+791
+12% +$36.7K 0.26% 77
2020
Q3 		$213K Buy
+6,566
New +$209K 0.21% 80

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Ellsworth Advisors's VCYT Position: Q1 2021 in Review

Ellsworth Advisors sold out of Veracyte (VCYT) in Q1 2021, closing a stake of 7,357 shares — an estimated $360K sold.

Ellsworth Advisors first reported a position in VCYT in Q3 2020 and held it in 2 quarters. The position peaked at $360K in Q4 2020. 235 funds tracked by Wall St. Rank hold VCYT as of Q1 2021.

  • Ellsworth Advisors reported no remaining Veracyte position as of Q1 2021 after selling out during the quarter.
  • Ellsworth Advisors sold 7,357 Veracyte shares in Q1 2021, an estimated $360K.
  • Ellsworth Advisors first reported a position in Veracyte in Q3 2020 and held it in 2 quarters.
  • Ellsworth Advisors's Veracyte position peaked at $360K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Veracyte as of Q1 2021.

Based on Ellsworth Advisors's 13F filing for Q1 2021, filed 21 Apr 2021.